SeaStar Medical Holding Corp

SeaStar Medical Holding Corp (Nasdaq: LMAO) is a medical technology company that entered the public markets through its 2022 de-SPAC merger with LMF Acquisition Opportunities, Inc., a blank-check vehicle sponsored by LMF Sponsor LLC that completed its IPO in 2021. The company develops selective cytopheretic device technology designed to address acute inflammatory conditions in critical care settings, placing it within the medical devices and healthcare technology sector. On May 13, 2026, SeaStar Medical filed an 8-K current report with the SEC, indicating a material corporate development in its post-merger public life. Sign up on SpacDesk for full filing data, deal histories, and real-time SPAC analytics.